| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Herpesvirus Infection1
Trudeau Institute, Saranac Lake, NY 12983
The human 
-herpesviruses, EBV and Kaposi’s sarcoma-associated
herpesvirus, establish life-long latency and can reactivate in
immunocompromised individuals. T cells play an important role in
controlling persistent EBV infection, whereas a role for humoral
immunity is less clear. The murine -herpesvirus-68 has biological
and structural similarities to the human -herpesviruses, and
provides an important in vivo experimental model for dissecting
mechanisms of immune control. In the current studies,
CD28-/- mice were used to address the role of Abs in
control of persistent murine -herpesvirus-68 infection. Lytic
infection was controlled in the lungs of CD28-/- mice,
and latency was maintained in B cells at normal frequencies. Although
class-switched virus-specific Abs were initially generated in the
absence of germinal centers, titers and viral neutralizing activity
rapidly waned. T cell depletion in CD28-/- mice with
compromised Ab responses, but not in control mice with intact Ab
responses, resulted in significant recrudescence from latency, both in
the spleen and the lung. Recrudescence could be prevented by passive
transfer of immune serum. These data directly demonstrate an important
contribution of humoral immunity to control of -herpesvirus latency,
and have significant implications for clinical
intervention.
This article has been cited by other articles:
|
|
 |
|
  N. S. Butler, A. A. Dandekar, and S. Perlman Antiviral Antibodies Are Necessary To Prevent Cytotoxic T-Lymphocyte Escape in Mice Infected with a Coronavirus J. Virol., December 15, 2007; 81(24): 13291 - 13298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kayhan, E. J. Yager, K. Lanzer, T. Cookenham, Q. Jia, T.-T. Wu, D. L. Woodland, R. Sun, and M. A. Blackman A Replication-Deficient Murine {gamma}-Herpesvirus Blocked in Late Viral Gene Expression Can Establish Latency and Elicit Protective Cellular Immunity J. Immunol., December 15, 2007; 179(12): 8392 - 8402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Cush, K. M. Anderson, D. H. Ravneberg, J. L. Weslow-Schmidt, and E. Flano Memory Generation and Maintenance of CD8+ T Cell Function during Viral Persistence J. Immunol., July 1, 2007; 179(1): 141 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fuse, S. Bellfy, H. Yagita, and E. J. Usherwood CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand J. Immunol., April 15, 2007; 178(8): 5227 - 5236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-J. Kim, C. E. Burkum, T. Cookenham, P. L. Schwartzberg, D. L. Woodland, and M. A. Blackman Perturbation of B Cell Activation in SLAM-Associated Protein-Deficient Mice Is Associated with Changes in Gammaherpesvirus Latency Reservoirs J. Immunol., February 1, 2007; 178(3): 1692 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fuse, J. J. Obar, S. Bellfy, E. K. Leung, W. Zhang, and E. J. Usherwood CD80 and CD86 Control Antiviral CD8+ T-Cell Function and Immune Surveillance of Murine Gammaherpesvirus 68. J. Virol., September 1, 2006; 80(18): 9159 - 9170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Tarakanova, F. Suarez, S. A. Tibbetts, M. A. Jacoby, K. E. Weck, J. L. Hess, S. H. Speck, and H. W. Virgin IV Murine Gammaherpesvirus 68 Infection Is Associated with Lymphoproliferative Disease and Lymphoma in BALB {beta}2 Microglobulin-Deficient Mice J. Virol., December 1, 2005; 79(23): 14668 - 14679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Barton, M. L. Lutzke, R. Rochford, and H. W. Virgin IV Alpha/Beta Interferons Regulate Murine Gammaherpesvirus Latent Gene Expression and Reactivation from Latency J. Virol., November 15, 2005; 79(22): 14149 - 14160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Lee, F. Giannoni, A. Lyon, S. Yada, B. Lu, C. Gerard, and S. R. Sarawar Role of CXCR3 in the Immune Response to Murine Gammaherpesvirus 68 J. Virol., July 15, 2005; 79(14): 9351 - 9355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Giannoni, A. B. Lyon, M. D. Wareing, P. B. Dias, and S. R. Sarawar Protein Kinase C {theta} Is Not Essential for T-Cell-Mediated Clearance of Murine Gammaherpesvirus 68 J. Virol., June 1, 2005; 79(11): 6808 - 6813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Braaten, R. L. Sparks-Thissen, S. Kreher, S. H. Speck, and H. W. Virgin IV An Optimized CD8+ T-Cell Response Controls Productive and Latent Gammaherpesvirus Infection J. Virol., February 15, 2005; 79(4): 2573 - 2583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Stewart, O. J. Silvia, I. M. D. Atkin, D. J. Hughes, B. Ebrahimi, and H. Adler In Vivo Function of a Gammaherpesvirus Virion Glycoprotein: Influence on B-Cell Infection and Mononucleosis J. Virol., October 1, 2004; 78(19): 10449 - 10459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sparks-Thissen, D. C. Braaten, S. Kreher, S. H. Speck, and H. W. Virgin IV An Optimized CD4 T-Cell Response Can Control Productive and Latent Gammaherpesvirus Infection J. Virol., July 1, 2004; 78(13): 6827 - 6835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. McClellan, S. A. Tibbetts, S. Gangappa, K. A. Brett, and H. W. Virgin IV Critical Role of CD4 T Cells in an Antibody-Independent Mechanism of Vaccination against Gammaherpesvirus Latency J. Virol., July 1, 2004; 78(13): 6836 - 6845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Workman, L. S. Cauley, I.-J. Kim, M. A. Blackman, D. L. Woodland, and D. A. A. Vignali Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo J. Immunol., May 1, 2004; 172(9): 5450 - 5455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Hancock, F. M. Szaba, K. N. Berggren, M. A. Parent, I. K. Mullarky, J. Pearl, A. M. Cooper, K. H. Ely, D. L. Woodland, I.-J. Kim, et al. Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN{gamma}-inducible fibrinogen-like protein 2 PNAS, March 2, 2004; 101(9): 3005 - 3010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fowler and S. Efstathiou Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73 J. Gen. Virol., March 1, 2004; 85(3): 609 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Andreansky, H. Liu, H. Adler, U. H. Koszinowski, S. Efstathiou, and P. C. Doherty The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a {gamma}-herpesvirus PNAS, February 17, 2004; 101(7): 2017 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kano, M. Inaoka, and T. Shiohara Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia Arch Dermatol, February 1, 2004; 140(2): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mpandi, L. A. Otten, C. Lavanchy, H. Acha-Orbea, and D. Finke Passive Immunization with Neutralizing Antibodies Interrupts the Mouse Mammary Tumor Virus Life Cycle J. Virol., September 1, 2003; 77(17): 9369 - 9377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Macrae, E. J. Usherwood, S. M. Husain, E. Flano, I.-J. Kim, D. L. Woodland, A. A. Nash, M. A. Blackman, J. T. Sample, and J. P. Stewart Murid Herpesvirus 4 Strain 68 M2 Protein Is a B-Cell-Associated Antigen Important for Latency but Not Lymphocytosis J. Virol., September 1, 2003; 77(17): 9700 - 9709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-J. Kim, E. Flano, D. L. Woodland, F. E. Lund, T. D. Randall, and M. A. Blackman Maintenance of Long Term {gamma}-Herpesvirus B Cell Latency Is Dependent on CD40-Mediated Development of Memory B Cells J. Immunol., July 15, 2003; 171(2): 886 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Tibbetts, J. Loh, V. van Berkel, J. S. McClellan, M. A. Jacoby, S. B. Kapadia, S. H. Speck, and H. W. Virgin IV Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection J. Virol., July 1, 2003; 77(13): 7696 - 7701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. van Dyk, H. W. Virgin IV, and S. H. Speck Maintenance of Gammaherpesvirus Latency Requires Viral Cyclin in the Absence of B Lymphocytes J. Virol., May 1, 2003; 77(9): 5118 - 5126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Flano, I.-J. Kim, J. Moore, D. L. Woodland, and M. A. Blackman Differential {gamma}-Herpesvirus Distribution in Distinct Anatomical Locations and Cell Subsets During Persistent Infection in Mice J. Immunol., April 1, 2003; 170(7): 3828 - 3834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Paciorkowski, L. D. Shultz, and T. V. Rajan Primed Peritoneal B Lymphocytes Are Sufficient To Transfer Protection against Brugia pahangi Infection in Mice Infect. Immun., March 1, 2003; 71(3): 1370 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Tibbetts, J. S. McClellan, S. Gangappa, S. H. Speck, and H. W. Virgin IV Effective Vaccination against Long-Term Gammaherpesvirus Latency J. Virol., February 15, 2003; 77(4): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Finke, S. A. Luther, and H. Acha-Orbea The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development PNAS, January 7, 2003; 100(1): 199 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Flano, I.-J. Kim, D. L. Woodland, and M. A. Blackman {gamma}-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells J. Exp. Med., November 18, 2002; 196(10): 1363 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gangappa, S. B. Kapadia, S. H. Speck, and H. W. Virgin IV Antibody to a Lytic Cycle Viral Protein Decreases Gammaherpesvirus Latency in B-Cell-Deficient Mice J. Virol., October 17, 2002; 76(22): 11460 - 11468. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
